p38 MAPK downregulates phosphorylation of Bad in doxorubicin-induced endothelial apoptosis
- 1 September 2006
- journal article
- Published by Elsevier in Biochemical and Biophysical Research Communications
- Vol. 347 (3) , 781-790
- https://doi.org/10.1016/j.bbrc.2006.06.159
Abstract
No abstract availableKeywords
This publication has 51 references indexed in Scilit:
- p38 MAPK regulates phosphorylation of Bad via PP2A-dependent suppression of the MEK1/2-ERK1/2 survival pathway in TNF-α induced endothelial apoptosisCellular Signalling, 2006
- Coenzyme Q10 for Prevention of Anthracycline-Induced CardiotoxicityIntegrative Cancer Therapies, 2005
- p38 MAPK mediates TNF-induced apoptosis in endothelial cells via phosphorylation and downregulation of Bcl-xLExperimental Cell Research, 2004
- Doxorubicin Induces Apoptosis in Normal and Tumor Cells via Distinctly Different MechanismsJournal of Biological Chemistry, 2004
- Anti-tumor efficacy of tumor vasculature-targeted liposomal doxorubicinJournal of Controlled Release, 2003
- Adriamycin-induced Cardiomyocyte and Endothelial Cell Apoptosis: In Vitro and In Vivo StudiesJournal of Molecular and Cellular Cardiology, 2002
- MAPK signal pathways in the regulation of cell proliferation in mammalian cellsCell Research, 2002
- Doxorubicin-induced apoptosis: Implications in cardiotoxicityMolecular and Cellular Biochemistry, 2002
- Doxorubicin-induced Apoptosis in Endothelial Cells and Cardiomyocytes Is Ameliorated by Nitrone Spin Traps and EbselenJournal of Biological Chemistry, 2000
- Early and delayed clinical cardiotoxicity of doxorubicinCancer, 1985